AbbVie
ABBV
$258.25
Share price
3.22%
Change (1 day)
12.30%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
AbbVie (ABBV) - Net assets
Net assets on the balance sheet as of December 2024 : C$4.66 Billion
According to AbbVie's latest financial reports the company has C$4.66 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
AbbVie - Net assets on balance sheet (from 2011 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $C$4.82 B | -64.99% |
| 2023-12-31 | $C$13.79 B | -41.21% |
| 2022-12-31 | $C$23.45 B | 19.24% |
| 2021-12-31 | $C$19.67 B | 17.8% |
| 2020-12-31 | $C$16.69 B | -256.46% |
| 2019-12-31 | $-C$10.68 Billion | -7.23% |
| 2018-12-31 | $-C$11.51 Billion | -279.54% |
| 2017-12-31 | $C$6.40 B | 2.86% |
| 2016-12-31 | $C$6.23 B | 13.84% |
| 2015-12-31 | $C$5.47 B | 170.71% |
| 2014-12-31 | $C$2.02 B | -57.72% |
| 2013-12-31 | $C$4.78 B | 42.99% |
| 2012-12-31 | $C$3.34 B | -72.45% |
| 2011-12-31 | $C$12.13 B | -22.68% |
| 2010-12-31 | $C$15.69 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 | C$122.75 B | 2,530.71% | 🇺🇸 USA |
 | C$22.73 B | 387.16% | 🇺🇸 USA |
 | C$19.79 B | 324.24% | 🇺🇸 USA |
 | C$8.15 B | 74.70% | 🇺🇸 USA |
 | C$26.69 B | 472.12% | 🇺🇸 USA |
 | C$23.18 B | 396.91% | 🇺🇸 USA |
 | C$22.77 B | 388.16% | 🇬🇧 UK |
 | C$56.69 B | 1,114.95% | 🇬🇧 UK |
 | C$3.59 B | -23.02% | 🇺🇸 USA |